Home / Recalls / Upsher Smith Laboratories, Inc. / D-160-2013

D-160-2013 Class II Terminated

Recalled by Upsher Smith Laboratories, Inc. — Maple Grove, MN

Recall Details

Product Type
Drugs
Report Date
February 20, 2013
Initiation Date
November 20, 2012
Termination Date
July 12, 2013
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
60 bottles

Product Description

Propranolol Hydrochloride Extended-release Capsules, USP, 80 mg, 100 Capsules, Rx only, Manufactured for Upsher Smith Laboratories, Inc Minneapolis MN 55447 --- NDC 0245-0085-11, UPC 3 0245-0085-11 9

Reason for Recall

Failed Dissolution Test Requirements

Distribution Pattern

FL, NJ.

Code Information

Lot #308198, Expiration Date is 03/2014

Other recalls by Upsher Smith Laboratories, Inc.

  • D-1836-2019 Class II — Bexarotene Capsules, 75 mg, 100 capsules per bottle, Rx Only, Manufactured for: (July 29, 2019)
  • D-0280-2019 Class II — Bumetanide Tablets, USP, 1 mg, 100-count bottle, Rx only, Manufactured by: Upse (September 19, 2018)
  • D-0281-2019 Class II — Bumetanide Tablets, USP, 2 mg, 100-count bottle, Rx only, Manufactured by: Upse (September 19, 2018)
  • D-1255-2014 Class III — Oxandrolone Tablets, USP, 10 mg, Rx Only, C-III, 60-count bottle, Manufactured f (April 14, 2014)
  • D-127-2013 Class III — Divalproex Sodium Delayed-Release Tablets, USP, 500 mg Valproic Acid Activity, 1 (December 10, 2012)